A Comparative Study between Abrus cantoniensis and Abrus mollis: Flavonoids Profiles by UPLC‐Q‐TOF‐MS and Anti‐Inflammatory Mechanism by Transcriptomics
-
Published:2023-06
Issue:6
Volume:20
Page:
-
ISSN:1612-1872
-
Container-title:Chemistry & Biodiversity
-
language:en
-
Short-container-title:Chemistry & Biodiversity
Author:
Liang Zhike1,
Chen Zhixia2,
Xue Xianmei1,
He Cuimin1,
Yuan Xujiang1ORCID
Affiliation:
1. Center of New Drug Research and Development/Guangdong Provincial Key Laboratory of New Drug Dosage Form/Key Laboratory of Modern Chinese Medicine Department of Education of Guangdong Province/Traditional Chinese Medicine Preparation Laboratory National Administration of Traditional Chinese Medicine (LevelIII) Guangdong Pharmaceutical University Guangzhou 510006 China
2. Phytomed Medicinal Herbs Auckland 1026 New Zealand
Abstract
AbstractAbrus mollis (MJGC) has been used as a substitute herb for Abrus cantoniensis (JGC) in China. However, an in‐depth comparison on their key metabolites and the mechanism of anti‐inflammation between these two is not available. In this report, high pressure liquid chromatography equipped with mass spectrometry was applied to capture their flavonoid profiles; transcriptomics was adopted to analyze their anti‐inflammatory mechanisms. The results showed that the main flavonoids in MJGC were vicenin‐2, schaftoside and isoschaftoside, while those in JGC were vicenin‐1 isomer and schaftoside isomer. The anti‐inflammatory activity of JGC was slightly stronger than that of MJGC. The number of differential expression genes regulated by JGC was significantly higher than MJGC. JGC regulated 151 (42 up and 109 down) of inflammation related genes, while MJGC regulated 58 (8 up and 50 down) of inflammation related genes. The results of this study provided scientific evidence and guidance for the substitution of MJGC and JGC.
Funder
Natural Science Foundation of Guangdong Province
Guangdong Medical Research Foundation
Subject
Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering
Reference41 articles.
1. Chinese Pharmacopoeia Commission Chinese Pharmacopoeia the Medicine Science and Technology Press of China Beijing 2020 P. 203.
2. X. Yuan Study on Active Compounds and Quality Evaluation of Herba Abri Guangzhou University of Traditional Chinese Medicine 2013.
3. Abrusamide A and B, two hepatoprotective isomeric compounds from Abrus mollis Hance
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献